BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 31109983)

  • 1. A Guide to Understanding Antimicrobial Drug Dosing in Critically Ill Patients on Renal Replacement Therapy.
    Pistolesi V; Morabito S; Di Mario F; Regolisti G; Cantarelli C; Fiaccadori E
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.
    Pea F; Viale P; Pavan F; Furlanut M
    Clin Pharmacokinet; 2007; 46(12):997-1038. PubMed ID: 18027987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying pharmacokinetic/pharmacodynamic principles for optimizing antimicrobial therapy during continuous renal replacement therapy.
    Honore PM; Jacobs R; De Waele E; Spapen HD
    Anaesthesiol Intensive Ther; 2017; 49(5):412-418. PubMed ID: 29171000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of antibiotics in continuous renal replacement therapies (CRRT)].
    Morabito S; Pistolesi V; Maggiore U; Fiaccadori E; Pierucci A
    G Ital Nefrol; 2012; 29(4):425-44. PubMed ID: 22843155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis.
    Heintz BH; Matzke GR; Dager WE
    Pharmacotherapy; 2009 May; 29(5):562-77. PubMed ID: 19397464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and antimicrobial dosing adjustment in critically ill patients during continuous renal replacement therapy.
    Kuang D; Verbine A; Ronco C
    Clin Nephrol; 2007 May; 67(5):267-84. PubMed ID: 17542336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug dosing in continuous renal replacement therapy: general rules.
    Schetz M
    Curr Opin Crit Care; 2007 Dec; 13(6):645-51. PubMed ID: 17975384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetic principles and drug-dosing adjustments during continuous renal replacement therapies (CRRT)].
    Morabito S; Guzzo I; Vitaliano E; Muzi L; Solazzo A; Pistolesi V; Pierucci A
    G Ital Nefrol; 2006; 23 Suppl 36():S127-38. PubMed ID: 17068740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of Commonly Used Medications in Children Receiving Continuous Renal Replacement Therapy: A Systematic Review of Current Literature.
    Dubinsky S; Watt K; Saleeb S; Ahmed B; Carter C; Yeung CHT; Edginton A
    Clin Pharmacokinet; 2022 Feb; 61(2):189-229. PubMed ID: 34846703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary?
    Blot S; Lipman J; Roberts DM; Roberts JA
    Diagn Microbiol Infect Dis; 2014 May; 79(1):77-84. PubMed ID: 24602849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machines that help machines to help patients: optimising antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal replacement therapy using dosing software.
    Roberts JA; Bellomo R; Cotta MO; Koch BCP; Lyster H; Ostermann M; Roger C; Shekar K; Watt K; Abdul-Aziz MH
    Intensive Care Med; 2022 Oct; 48(10):1338-1351. PubMed ID: 35997793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of continuous renal replacement therapy on linezolid pharmacokinetic/pharmacodynamics: a systematic review.
    Villa G; Di Maggio P; De Gaudio AR; Novelli A; Antoniotti R; Fiaccadori E; Adembri C
    Crit Care; 2016 Nov; 20(1):374. PubMed ID: 27863531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Con: Dialy- and continuous renal replacement (CRRT) trauma during renal replacement therapy: still under-recognized but on the way to better diagnostic understanding and prevention.
    Honoré PM; Jacobs R; Joannes-Boyau O; De Waele E; Van Gorp V; Boer W; Spapen HD
    Nephrol Dial Transplant; 2013 Nov; 28(11):2723-7; discussion 2727-8. PubMed ID: 24169609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy?
    Jamal JA; Mueller BA; Choi GY; Lipman J; Roberts JA
    Diagn Microbiol Infect Dis; 2015 May; 82(1):92-103. PubMed ID: 25698632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial Dose Reduction in Continuous Renal Replacement Therapy: Myth or Real Need? A Practical Approach for Guiding Dose Optimization of Novel Antibiotics.
    Gatti M; Pea F
    Clin Pharmacokinet; 2021 Oct; 60(10):1271-1289. PubMed ID: 34125420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of Commonly Used Antimicrobials in Critically Ill Adults During Extracorporeal Membrane Oxygenation: A Systematic Review.
    Duceppe MA; Kanji S; Do AT; Ruo N; Cavayas YA; Albert M; Robert-Halabi M; Zavalkoff S; Dupont P; Samoukovic G; Williamson DR
    Drugs; 2021 Jul; 81(11):1307-1329. PubMed ID: 34224115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents.
    Blot SI; Pea F; Lipman J
    Adv Drug Deliv Rev; 2014 Nov; 77():3-11. PubMed ID: 25038549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.
    Pea F; Viale P; Furlanut M
    Clin Pharmacokinet; 2005; 44(10):1009-34. PubMed ID: 16176116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drugs dosing in intensive care unit during continuous renal replacement therapy].
    Bourquin V; Ponte B; Saudan P; Martin PY
    Nephrol Ther; 2009 Nov; 5(6):533-41. PubMed ID: 19369134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A primer on continuous renal replacement therapy for critically ill patients.
    Joy MS; Matzke GR; Armstrong DK; Marx MA; Zarowitz BJ
    Ann Pharmacother; 1998 Mar; 32(3):362-75. PubMed ID: 9533067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.